Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this prospective, randomized, double-blinded, active-controlled study is:
To assess the effectiveness of systemic administration of lidocaine and esmolol in
combination (vs. either drug alone) will result in improved postoperative outcomes for
patients undergoing abdominal surgery (e.g., less pain and postoperative constipation, nausea
and vomiting, faster return of bowel function, resumption of normal activities of daily
living), leading to a shorten length of hospital stay, maintaining hemodynamic stability
during general anesthesia, when administered as intravenous adjuvants